Month: March 2024

Heightens Focus on Valuable Patent Portfolio; Engages Investment Bank to Assist in Exploration of Strategic Alternatives for Parent Company GRANT-VALKARIA, Fla., March 27, 2024 (GLOBE NEWSWIRE) — Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival Brands” or the “Company,”), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC (“Bidi Vapor”), on Monday announced its financial results for the fiscal 2024 first quarter ended January 31, 2024 and provided a business update. Recent Business HighlightsReduced net inventories to $2.1 million as of January 31, 2024, down 49.5% from $4.1 million as of October 31, 2023. Terminated service agreement with QuikFillRx (d/b/a Kaival Marketing Services), the third-party service provider responsible for increasing sales...

Next-gen power semiconductors enable robust, efficient, grid-connected applications as part of a $1.3 trillion electrification opportunityNavitas Delivers Grid-Connected Energy with 3.3 kV SiC and Bi-directional GaN ICs at PE International 2024Next-gen power semiconductors enable robust, efficient, grid-connected applications as part of a $1.3 trillion electrification opportunityTORRANCE, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry leader in gallium nitride (GaN) power ICs and silicon carbide (SiC) technology, has announced its participation in the upcoming Power Electronics International conference on April 16th– 17th 2024, in Brussels, Belgium. Grid reliability is a key factor in a $1.3 trillion power...

ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced that Mark Duff, Chief Executive Officer of Perma-Fix, will be presenting at the 10th Annual Gabelli & Company Waste Services Symposium, being held on Thursday, April 4th at the Harvard Club in New York City. Mr. Duff is scheduled to present at 1:15 PM ET. Management will also be participating in one-on-one meetings with qualified investors throughout the conference. To request a meeting, please contact James Carey at Gabelli & Company: jcarey@gabelli.com. The 10th Annual Gabelli & Company Waste Services Symposium draws companies with a focus on the themes of waste, water treatment, and the environment. This timely conference will feature presentations by senior management of several leading...

Featuring Exclusive Live Performance by Breaking Artist Tabi streamed on Liveone.com to over 220 countries Panel Discussion with World-Class Female Entertainment Industry Executives LiveOne Team is over 40% Female, Outperforming Industry Average of 30% LiveOne has Streamed Over 1K Top Female Artists, including Taylor Swift, Adele and Olivia Rodrigo, to 100M+ Viewers Fans Can Watch on Saturday, March 30th at 5:00pm PT on LiveOne.com LOS ANGELES, CA, March 27, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today that it will stream the latest edition of LiveOne Presents: Celebrating Women in the Entertainment Industry. In recognition of Women’s History Month, the event will include a performance by artist and songwriter,...

JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry events during the month of April 2024. World Vaccine Congress | WashingtonWalter E. Washington Convention Center, Washington D.C.April 3, 2024 Booth #551Presentation: New Vaccine Development “The thermophilic filamentous fungus, C1 – an extraordinary platform for the production of prophylactics for humans and animals” The Future of Protein ProductionMcCormick...

MONTREAL, March 27, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC – “Earth Alive” or the “Company”), a company that develops, manufactures, and distributes exclusive microbial-based solutions and products, at the forefront of technology and environmentally friendly, today announces a distribution agreement with Bourget, a pioneer in road maintenance in Quebec. This strategic partnership is intended to strengthen Earth Alive’s presence in the Quebec market. For over 60 years, Bourget has provided the most effective ecological solutions to maintain Quebec’s road network. With its central facilities in Saint-Paul in Lanaudière and its numerous spreader truck fleet, Bourget ensures unparalleled proximity to its customers, reinforcing its commitment for a strong and...

CAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences in April. Cantor Virtual Muscular Dystrophy Symposium Date: Wednesday, April 3, 2024Analyst-led fireside chat presentation time: 3:10 p.m. ET 23rd Annual Needham Virtual Healthcare Conference Date: Thursday, April 11, 2024Company presentation time: 8:45 a.m. ET Live webcasts of these presentations will be available on the Investor Relations page of the Wave Life Sciences website at http://ir.wavelifesciences.com. Replays of these presentations will be archived and available...

SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceutical (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that management will give a virtual company presentation at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders, to be held virtually on Thursday, March 28, 2024. ASLAN management will also be available for one-on-one meetings with investors on the day of the conference. Please register for the event via this link or contact your representative at H.C. Wainright to schedule a meeting.    Company Presentation Information Format: Virtual presentation Presenter: Carl Firth, CEO, ASLAN Pharmaceuticals Date: Thursday,...

– Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial – Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 – All-stock merger of equals transaction with Ceapro, Inc. expected to close in the second quarter of 2024 TORONTO, ONTARIO, March 27, 2024 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the year ended December 31, 2023 and provided an update on the completion of enrollment for its ongoing Phase 3 safety and efficacy study AEZS-130-P02 (the “DETECT-trial”) evaluating...

CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, CEO of Catalyst, along with other members of Catalyst’s management team, will participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium taking place virtually on April 2-3, 2024.Presentation Details:Event: Cantor Virtual Muscular Dystrophy SymposiumDate:  April 2, 2024Time: 3:10 PM ET   The presentation webcast will be available on the Investors section of the Company’s website, and a replay will be accessible for at least 14 days. About Catalyst PharmaceuticalsWith...